Fred’s Reports Fourth Quarter and Fiscal Year 2018 Results
来源: Nasdaq GlobeNewswire / 06 五月 2019 05:00:02 America/New_York
MEMPHIS, Tenn., May 06, 2019 (GLOBE NEWSWIRE) -- Fred’s, Inc. (NASDAQ: FRED) reported financial results for the fourth quarter and fiscal year ended February 2, 2019. Except as otherwise noted, the results contained herein have been adjusted for discontinued operations related to the sale of Fred’s specialty pharmacy business to an affiliate of CVS Health Corporation and certain assets of Fred’s retail pharmacy business to Walgreen Co. The amounts and percentages presented below, for all periods, reflect the results of operations and financial conditions from Fred’s continuing operations.
Joe Anto, Fred’s CEO, stated “This is clearly a challenging time for the Company and we are disappointed with our operating results for the quarter and fiscal year. We are working to optimize our store footprint, cost structure and operating model, while also addressing concerns regarding our liquidity profile. As of April 30, 2019, our ABL balance stood at $78.3 million versus $58.6 million at the end of Q4. Additionally, we are working on various sale processes for non-core assets, including certain real estate and our remaining pharmacy script portfolio.”
Fourth Quarter Fiscal 2018 vs. Fourth Quarter Fiscal 2017
- Net sales were down 17.2% to $307.1 million in Q4 2018 versus $370.9 million in Q4 2017.
- Comparable store sales decreased 9.7% in Q4 2018 compared to a decline of 4.8% in the same period of 2017.
- Gross profit decreased 22.1% to $71.7 million in Q4 2018 versus $92.1 million in Q4 2017.
- Gross margin as a percentage of sales decreased approximately 147 basis points to 23.4% in Q4 2018 versus 24.8% in Q4 2017.
- Total selling, general, and administrative expenses were $136.7 million in Q4 2018, or 44.5 % of sales, compared to $113.2 million in Q4 2017, or 30.5% of sales.
- Selling, general, and administrative expenses, adjusted for non-recurring items, were $102.6 million in Q4 2018, or 33.4% of sales, compared to $108.4 million in Q4 2017, or 29.2% of sales.
- Impairment expense of $31.7 million was recorded during Q4 2018 of certain assets related to the decline in the results of operations compared to the $2.5 million recorded in Q4 2017.
- Net loss from continuing operations was $67.2 million, or $(1.86) per share, in Q4 2018, compared to a loss of $25.4 million, or $(0.68) per share, in Q4 2017.
- Adjusted EBITDA, a non-GAAP financial measure, was $(17.7) million in Q4 2018 compared to $31.4 million in Q4 2017.
Fiscal Year 2018 vs. Fiscal Year 2017
- Net sales were down 8.9% to $1,271.7 million in fiscal 2018 versus $1,395.8 million in fiscal 2017.
- Comparable store sales decreased 1.7% in fiscal 2018 compared to a decline of 2.5% in fiscal 2017.
- Gross profit decreased 11.2% to $323.0 million in fiscal 2018 versus $363.8 million in fiscal 2017.
- Gross margin as a percentage of sales decreased approximately 70 basis points to 25.4% in fiscal 2018 versus 26.1% in fiscal 2017.
- Total selling, general, and administrative expenses were $452.5 million in fiscal 2018, or 35.6% of sales, compared to $500.8 million, or 35.9% of sales, in fiscal 2017.
- Selling, general, and administrative expenses, adjusted for non-recurring items, were $409.3 million, or 32.2% of sales, in fiscal 2018 compared to $439.2 million, or 31.5% of sales, in fiscal 2017.
- Impairment expense of $33.2 million was recorded in fiscal 2018 compared to $2.5 million recorded in fiscal 2017.
- Net loss from continuing operations was $137.2 million, or $(3.76) per share, in fiscal 2018, compared to a loss of $144.5 million, or $(3.87) per share, in fiscal 2017.
- Adjusted EBITDA, a non-GAAP financial measure, was $(48.1) million in fiscal 2018 compared to $20.3 million in fiscal 2017.
Fourth Quarter 2018 Results
Fred’s net sales for the fourth quarter of fiscal 2018 decreased 17.2% to $307.1 million from $370.9 million in the fourth quarter last year. Comparable store sales for the quarter decreased 9.7% compared to a 4.8% decrease in the fourth quarter of last year.
Fred’s gross profit for the fourth quarter of 2018 decreased 22.1% to $71.7 million from $92.1 million in the prior year period. Gross margin percentage for the quarter decreased 147 basis points to 23.4% from 24.8% in the same quarter last year.
Total selling, general and administrative expenses for the fourth quarter increased $23.6 million to $136.7 million compared to last year’s fourth quarter of $113.2 million. As a percentage of sales, total selling, general and administrative expenses, increased 1,400 basis points to 44.5% of sales from 30.5% of sales in the fourth quarter last year.
Adjusted selling, general and administrative expenses, a non-GAAP financial measure that excludes non-recurring items, decreased to $102.6 million, or 33.4% of sales, in Q4 of 2018 compared to $108.4 million, or 29.2% of sales, in Q4 of 2017.
Due primarily to the reduction in the estimated fair value of fixed assets and intangibles related to underperforming stores, Fred’s recorded an impairment expense of $31.7 million in the fourth quarter of 2018. Comparatively, in the fourth quarter of 2017, Fred’s recorded impairment expense of $2.5 million.
For the fourth quarter of 2018, Fred’s recorded a net loss from continuing operations of approximately $67.2 million, or $(1.86) per share, compared to a net loss of $25.4 million, or $(0.68) per share, during the same period in 2017.
Adjusted EBITDA, a non-GAAP financial measure that further excludes depreciation and amortization and non-recurring items from EBIT, was $(17.7) million compared to $31.4 million in the fourth quarter of 2017.
Fiscal Year End 2018 Results
Net sales for 2018 decreased to $1.272 billion from $1.396 billion in 2017 for a year-over-year decrease of $124.1 million or 8.9%. Comparable store sales for 2018 decreased 1.6% from the same period last year. Front store (non-pharmacy) sales decreased 11.8% over 2017 front store sales. The decrease year over year was primarily due to the clearance of merchandise that management identified as under-productive combined with our out of stock position of many key front store items.
Fred’s gross profit for the year decreased to $323.0 million in 2018 from $363.8 million in 2017, a year-over-year decrease of $40.8 million, or 11.2%. Gross margin rate, measured as a percentage of net sales, decreased to 25.4% in 2018 from 26.1% in 2017, an approximately 70-basis point decline. Factors contributing to the decline in gross margin were related to continued pressures Fred’s experienced in its retail pharmacy business, specifically related to prescription rebates in 2017 that did not recur in 2018 and an increase in DIR fees paid to PBMs. In the front store, gross margin was impacted by promotional markdowns as well as a shift in sales mix from general merchandise to food and consumables.
Total selling, general and administrative expenses decreased to $452.5 million, or 35.6% of sales, in 2018 from $500.8 million, or 35.9% of sales, in 2017. This decrease was primarily due to the impact of bank fees, financing termination fees and professional fees incurred in 2017 related to the attempted Rite Aid acquisition and the closing of 39 underperforming stores in the prior year that were not repeated in 2018. Additionally, costs decreased as a result of the cost containment measures experienced during fiscal 2018.
Adjusted selling, general and administrative expenses, a non-GAAP financial measure that excludes non-recurring items, decreased to $409.3 million, or 32.2% of sales, for the fiscal year 2018 compared to $439.2 million, or 31.5% of sales, for the same period in 2017.
Impairment expense of $33.2 million was recorded in fiscal 2018 related to long lived assets, including intangibles related to the decline in the results of operations compared to the $2.5 million recorded in fiscal 2017.
Net loss from continuing operations decreased $7.3 million to $137.2 million, or $(3.76) per share, in 2018 from a loss of $144.5 million, or $(3.87) per share, in 2017.
Adjusted EBITDA, a non-GAAP financial measure that further excludes depreciation and amortization and non-recurring items from EBIT, was $(48.1) million for fiscal year 2018 compared to $20.3 million in 2017.
Going Concern; Other Matters
As further detailed in Fred’s Annual Report on Form 10-K for the fiscal year ended February 2, 2019, filed with the Securities and Exchange Commission on May 3, 2019, the report of Fred’s independent registered public accounting firm includes an explanatory paragraph indicating that there is substantial doubt about Fred’s ability to continue as a going concern. The receipt of this explanatory paragraph with respect to Fred’s financial statements for the year ended February 2, 2019 will result in a breach of a covenant under Fred’s Revolving Credit Agreement, which will constitute an event of default under such agreement. In addition, Fred’s lenders under the Revolving Credit Agreement have indicated to Fred’s their belief that certain other events of default have occurred under the Revolving Credit Agreement in connection with Fred’s previously-announced closure of 159 stores, the inventory sales at certain stores and the timing of delivery, and content, of a borrowing base certificate due under the Revolving Credit Agreement. An event of default, which is not cured or waived, may permit acceleration of Fred’s indebtedness under the Revolving Credit Agreement, among other remedies. Fred’s is currently seeking an agreement with its lenders pursuant to which such lenders would forbear for a period of time from seeking remedies on account of, or waive, the foregoing events or potential events of default, but there is no assurance that Fred’s will receive such forbearance or waivers.
Fred’s will hold a conference call today at 8:00 a.m. Eastern Time to discuss these results.
Date: Monday, May 6, 2019
Time: 8:00 a.m. Eastern Time
Toll-free dial-in number: 1-877-407-4018
International dial-in number: 1-201-689-8471
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please press *0 for operator assistance, or click “help” on the webcast.
The conference call will be broadcast live and available for replay at http://public.viavid.com/player/index.php?id=134348 and via the investor relations section of the Company’s website at investors.fredsinc.com .
A replay of the conference call will also be available by telephone after 11:00 a.m. Eastern time on May 6, 2019 through May 20, 2019.
Toll-free replay number: 1-844-512-2921
International replay number: 1-412-312-6671
Non-GAAP Financial Measures
The Company’s management believes that the disclosure of Adjusted selling, general and administrative expenses, Adjusted EBITDA and Free Cash Flow provides useful information to investors because the measures present an alternative and more relevant method for measuring the Company’s results of operations and financial condition, and, when viewed together with the Company’s GAAP results and the accompanying reconciliations, provide a more complete understanding of the factors and trends affecting the Company than the GAAP results alone.
Adjusted EBITDA is calculated as loss before interest and other income and expense, income tax benefit, depreciation and amortization, and non-recurring items. Non-recurring items include discontinued operations, impairment, closed stores, professional fees, stock compensation, LIFO adjustments, and other. Adjusted selling, general and administrative expenses, including depreciation and amortization, is calculated as selling, general and administrative expenses, including depreciation and amortization and excludes certain non-recurring items, such as closed stores, non-recurring professional fees, severance, and other non-recurring items. The exclusion of certain expenses in calculating Adjusted EBITDA and Adjusted selling, general and administrative expenses, including depreciation and amortization, facilitate operating performance comparisons on a period-to-period basis and excludes items that Fred’s does not consider to be indicative of our core operating performance. Accordingly, Fred’s believes that Adjusted EBITDA and Adjusted selling, general and administrative expenses, including depreciation and amortization, provide useful information to investors and others in understanding and evaluating our operating results in the same manner as Fred’s management and board of directors. Additionally, Adjusted EBITDA is a common alternative measure of financial performance used by investors, financial analysts, and rating agencies. These groups use Adjusted EBITDA, along with other measures, to estimate the value of a company and to compare the operating performance of a company to others in its industry. A reconciliation of these non-GAAP financial measures to their most directly comparable GAAP measure appears in the financial tables attached to this news release.
The Company defines Free Cash Flow, which is a non-GAAP financial measure, as net cash provided by operating activities less expenditures for property, plant, and equipment, and any proceeds from asset dispositions, both of which are reported in our Condensed Consolidated Statement of Cash Flows. The Company believes that Free Cash Flow is one of several benchmarks used by analysts and investors for comparisons of liquidity with other companies within the industry, although the Company’s measure of Free Cash Flow may not be directly comparable to similar measures reported by other companies.
About Fred’s, Inc.
Since 1947, Fred’s, Inc. has been an integral part of the communities it serves throughout the Southeastern United States. Today, Fred’s operates approximately 557 discount value stores and its mission is to make it easy AND exciting to save money. Its unique format offers customers a full range of value-priced everyday items, along with terrific deals on closeout merchandise throughout the store. For more information about the Company, visit Fred’s website at www.fredsinc.com.
Cautionary Statement Regarding Forward-looking Information
Comments in this press release that are not historical facts are forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to differ materially from those projected in the forward-looking statements. A reader can identify forward-looking statements because they are not limited to historical facts or they use such words as “outlook,” “guidance,” “may,” “should,” “could,” “believe,” “anticipate,” “project,” “plan,” “expect,” “estimate,” “objective,” “forecast,” “goal,” “intend,” “committed,” “continue,” or “will likely result” and similar expressions that concern the Company’s strategy, plans, intentions or beliefs about future occurrences or results. Forward-looking statements involve estimates, expectations, projections, goals, forecasts, assumptions, risks and uncertainties. Forward-looking statements include, but are not limited to, statements about future financial and operating results, the Company’s plans, objectives, business outlook, priorities, expectations and intentions, expectations for sales growth, comparable sales, earnings and performance, shareholder value, capital expenditures, cash flows, demand for products, share repurchases, strategic initiatives, including those relating to store closures and acquisitions and dispositions by the Company and the expected impact of such transactions on our strategic and operational plans and financial results, and any statement of an assumption underlying any of the foregoing and other statements that are not historical facts. Although we believe that the expectations, opinions, projections and comments reflected in these forward-looking statements are reasonable, such statements involve risks and uncertainties and we can give no assurance that such statements will prove to be correct. A wide variety of potential risks, uncertainties and other factors could materially affect our ability to achieve the results either expressed or implied by these forward-looking statements including, but not limited to risks and uncertainties associated with: (i) the competitive nature of the industries in which we operate; (ii) our turnaround plan and the implementation of our strategic initiatives, and their impact on our sales, costs and operations; (iii) our store closures and the related sales of inventory and real estate issues; (iv) our divestitures; (v) utilizing our existing and new stores and the extent of our pharmacy department presence in new and existing stores; (vi) conditions affecting the retail sector as a whole; (vii) our reliance on a single supplier of pharmaceutical products; (viii) our pharmaceutical drug pricing; (ix) reimbursement rates and the terms of our agreements with pharmacy benefit management companies; (x) consolidation in the healthcare industry; (xi) our private brands; (xii) the seasonality of our business and the impact of adverse weather conditions; (xiii) operational, supply chain and distribution difficulties; (xiv) merchandise supply and pricing; (xv) consumer demand and product mix; (xvi) delayed openings and operating new stores and distribution facilities; (xvii) our employees; (xviii) risks relating to payment processing; (xix) our computer systems, and the processes supported by our information technology infrastructure; (xx) our ability to protect the personal information of our customers and employees; (xxi) cyber-attacks; (xxii) changes in governmental regulations; (xxiii) the outcome of legal proceedings, including claims of product liability; (xxiv) insurance costs; (xxv) tax assessments and unclaimed property audits; (xxvi) current economic conditions; (xxvii) our indebtedness and our ability to satisfy our debt obligations and obtain forbearance or waivers for any defaults; (xxviii) the terms of our existing and future indebtedness, including the covenants set forth in the documents governing such indebtedness; (xxix) any acquisitions we may pursue and the ability to effectively integrate businesses that we acquire; (xxx) our ability to remediate the material weaknesses in our internal controls over financial reporting and otherwise maintain effective internal controls over financial reporting; (xxxi) our largest stockholder holding a significant percentage of our outstanding equity; (xxxii) our ability to pay dividends and/or repurchase shares of our Class A voting common stock; (xxxiii) our ability to attract and retain talented executives; (xxxiv) any strategic alternatives that we decide to pursue, if any; (xxxv) our ability to continue as a going concern; and (xxxvi) the factors listed under Item 1A: “Risk Factors” in our most recent Annual Report on Form 10-K and in any subsequent quarterly filings on Form 10-Q filed with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made. The Company undertakes no obligation to release revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unforeseen events, except as required to be reported under the rules and regulations of the Securities and Exchange Commission.
Jen Ehlers, Fred’s, Inc.
Reconciliation of Unaudited Net Loss to Adjusted EBITDA
A Non-GAAP Financial Measure
For the Period Ended For the Year Ended 13 Weeks 14 Weeks 52 Weeks 53 Weeks February 2,
Net Income (Loss) $ 68,728 $ (32,392 ) $ (12,967 ) $ (150,185 ) Interest expense 1,800 1,926 7,581 6,297 Income tax expense (benefit) 406 2,361 52 1,241 Operating income (loss) / EBIT 70,934 (28,105 ) (5,334 ) (142,647 ) Depreciation and amortization 7,254 8,968 31,273 35,301 EBITDA 78,188 (19,137 ) 25,939 (107,346 ) Adjustments: Stock compensation 594 13 3,279 4,619 LIFO adjustment 1,531 1,497 — 1,446 Closing stores — 338 — 16,676 Inventory impairment — 750 — 17,830 Professional fees related to attempted Rite Aid acquisition — 9,405 (909 ) 41,330 Professional fees for specialty and retail pharmacy discontinued operations 1,065 — 3,541 — Professional fees related to turnaround strategy 1,356 7,709 2,363 12,244 Walgreens reimbursement (Rite-Aid) — (25,000 ) — (25,000 ) Loss on sale of airplane — — — 2,599 Impairment of assets, including intangibles 31,737 2,489 33,243 2,489 Valuation allowance 3,747 37,116 3,747 37,116 Executive and other severance — — 4,938 852 Activism expenses — 6,050 — 6,650 Discontinued operations (135,960 ) 7,022 (124,216 ) 5,646 Other — 3,188 — 3,188 Adjusted EBITDA $ (17,742 ) $ 31,440 $ (48,075 ) $ 20,339
Reconciliation of Unaudited Selling, General, and Administrative Expenses, Including Depreciation and Amortization to Adjusted Selling, General, and Administrative Expenses, Including Depreciation and Amortization
A Non-GAAP Financial Measure
For the Period Ended For the Year Ended 13 Weeks 14 Weeks 52 Weeks 53 Weeks February 2, 2019 February 3, 2018 February 2, 2019 February 3, 2018 Total selling, general and administrative expenses $ 136,740 $ 113,176 $ 452,519 $ 500,788 Closing Stores — 338 — 18,173 Professional fees related to attempted Rite Aid acquisition — (15,595 ) (909 ) 18,555 Professional fees related to turnaround strategy 1,356 11,543 2,363 12,244 Professional fees for specialty and retail pharmacy discontinued operations 1,065 — 3,541 — Loss on sale of airplane — — — 2,599 Activism Expenses — 6,050 — 6,650 Impairment of assets 31,737 2,489 33,243 2,489 Executive and other Severance — — 4,938 852 Adjusted selling, general, and administrative expenses $ 102,582 $ 108,351 $ 409,343 $ 439,226
Free Cash Flow
A Non-GAAP Financial Measure
52 Weeks 53 Weeks February 2, 2019 February 3, 2018 Net cash used in operating activities $ (91,523 ) $ (44,703 ) Less capital expenditures (9,005 ) (15,753 ) Less asset acquisitions, net, primarily intangibles — (1,718 ) Add proceeds from asset dispositions 2,203 2,206 Add net proceeds from discontinued operations 215,469 — Free cash flow $ 117,144 $ (59,968 )
Unaudited Financial Highlights
(In thousands, except per share amounts)
13 Weeks 14 Weeks 52 Weeks
% Change February 2,
% Change Net sales $ 307,092 $ 370,865 -17.2 % $ 1,271,746 $ 1,395,845 -8.9 % Operating loss from continuing operations (65,026 ) (21,100 ) -208.2 % (129,550 ) (137,001 ) 5.4 % Net loss from continuing operations (67,232 ) (23,026 ) -192.0 % (137,183 ) (144,539 ) 5.1 % Net income (loss) from discontinued operations 135,960 (7,022 ) 2036.2 % 124,216 (5,646 ) 2300.1 % Net loss per share from continuing operations, basic and diluted (1.86 ) (0.68 ) (3.76 ) (3.87 ) Net income (loss) per share from discontinued operations, basic and diluted 3.77 (0.19 ) 3.40 (0.15 ) Average shares outstanding: Basic 36,073 37,461 36,510 37,392 Diluted 36,073 37,461 36,510 37,392
Unaudited Fiscal 2018 Fourth Quarter Results
(In thousands, except per share amounts)
For the Period Ended 13 Weeks 14 Weeks February 3, 2019 % of Net Sales February 2, 2018 % of Net Sales Net sales $ 307,092 100.0 % $ 370,865 100.0 % Cost of goods sold 235,378 76.6 % 278,789 75.2 % Gross profit 71,714 23.4 % 92,076 24.8 % Depreciation & amortization 7,254 2.4 % 8,968 2.4 % Impairment expense 31,737 10.3 % 2,489 0.7 % Selling, general and administrative expenses 97,749 31.8 % 101,719 27.4 % Operating loss from continuing operations (65,026 ) -21.3 % (21,100 ) -5.6 % Interest expense, net 1,800 0.6 % 1,926 0.5 % Loss from continuing operations before income taxes (66,826 ) -21.9 % (23,026 ) -6.1 % Income tax benefit 406 0.1 % 2,344 0.6 % Net loss from continuing operations (67,232 ) -22.1 % (25,370 ) -6.8 % Net income (loss) from discontinued operations 135,960 44.1 % (7,022 ) -1.9 % Net income (loss) $ 68,728 $ (32,392 ) Net loss per share from continuing, basic and diluted (1.86 ) (0.68 ) Net income (loss) per share from discontinued, basic and diluted 3.77 (0.19 ) Weighted average shares outstanding: Basic 36,073 37,461 Diluted 36,073 37,461
Fiscal Year Ended 2018
(In thousands, except per share amounts)
Fiscal Year Ended 52 Weeks 53 Weeks February 3, 2019 % of Net Sales February 2, 2018 % of Net Sales Net sales $ 1,271,746 100.0 % $ 1,395,845 100.0 % Cost of goods sold 948,777 74.6 % 1,032,058 73.9 % Gross profit 322,969 25.4 % 363,787 26.1 % Depreciation & amortization 31,273 2.5 % 35,301 2.5 % Impairment expense 33,243 2.6 % 2,489 0.2 % Selling, general and administrative expenses 388,003 30.5 % 462,998 33.2 % Operating loss from continuing operations (129,550 ) -10.2 % (137,001 ) -9.7 % Interest expense, net 7,581 0.6 % 6,297 0.5 % Loss from continuing operations before income taxes (137,131 ) -10.9 % (143,298 ) -10.2 % Income tax (benefit) expense 52 0.0 % 1,241 0.1 % Net loss from continuing operations (137,183 ) -11.0 % (144,539 ) -10.4 % Net income (loss) from discontinued operations 124,216 9.6 % (5,646 ) -0.4 % Net loss $ (12,967 ) $ (150,185 ) Net loss per share from continuing, basic and diluted (3.76 ) (3.87 ) Net income (loss) per share from discontinued, basic and diluted 3.40 (0.15 ) Weighted average shares outstanding: Basic 36,510 37,392 Diluted 36,510 37,392
Unaudited Balance Sheet
February 2, February 3, 2019 2018 ASSETS Current assets: Cash and cash equivalents $ 5,353 $ 6,573 Inventories 246,517 263,831 Receivables, less allowance for doubtful accounts 22,970 37,720 Other non-trade receivables 30,412 31,500 Current assets held for sale — 35,247 Prepaid expenses and other current assets 10,074 10,055 Total current assets 315,327 384,926 Property and equipment, less accumulated depreciation and amortization 66,346 110,539 Goodwill — — Noncurrent assets held for sale 4,839 67,185 Intangible assets, net 21,463 34,347 Other noncurrent assets, net 1,050 568 Total assets $ 409,025 $ 597,565 LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities: Accounts payable $ 97,107 $ 129,213 Current portion of indebtedness 58,641 65 Accrued expenses and other 58,352 67,977 Current liabilities held for sale — 26,572 Total current liabilities 214,100 223,827 Long-term portion of indebtedness 14,446 167,100 Noncurrent liabilities held for sale — 48 Other noncurrent liabilities 15,015 25,542 Total liabilities 243,560 416,517 Total shareholders’ equity 165,465 181,048 Total liabilities and shareholders’ equity $ 409,025 $ 597,565